Lambda COVID-19 Variant Shows Vaccine Resistance, New Study Suggests

A nurse is handed a dose of the Pfizer COVID-19 vaccine before administering it to a college student during a City of Long Beach Public Health Covid-19 mobile vaccination clinic at the California State University Long Beach (CSULB) campus in Long Beach, Calif., on Aug. 11, 2021 Patrick T. Fallon/AFP via Getty Images

Researchers in Japan have found the Lambda COVID-19 variant exhibits higher infectivity and immune resistance to vaccines than the version of the virus that first emerged in Wuhan, China.

A recently published preprint of a Japanese study, which has yet to be peer-reviewed, suggests said the Lambda variant, first detected in Peru, is able to resist vaccine-induced neutralizing antibodies that can fight off the CCP (Chinese Communist Party) virus.